Dehydrocorydaline (13-Methylpalmatine) hydroxyl is an alkaloid that regulates protein expression of Bax , Bcl-2 ; activates caspase-7 , caspase-8 , and inactivates PARP. Dehydrocorydaline hydroxyl elevates p38 MAPK activation. Anti-inflammatory and aAppearance:SolidIn Vitro:Dehydrocorydaline hydroxyl (0-200 μM) treatment significantly inhibits the growth of MCF-7 cells in a dose-dependent manner. The cell viability is decreased by approximate 40% after 24 h of 200 μM Dehydrocorydaline hydroxyl. Dehydrocorydaline hydroxyIn Vivo:Dehydrocorydaline hydroxyl manifests a low acute toxicity with an LD 50 of about 277.5±19.0mg/kg body weight in mice following oral administration and 21.1±1.4mg/kg for intraperitoneal injection. MCE has not independently confirmed the accuracy ofBiological Activity:Dehydrocorydaline (13-Methylpalmatine) hydroxyl is an alkaloid that regulates protein expression of Bax , Bcl-2 ; activates caspase-7, caspase-8 , and inactivates PARP . Dehydrocorydaline hydroxyl elevates p38 MAPK activation. Anti-inflammatory and anti-c.
Specifications and Purity: ≥99%
Molecular Formula: C22H25NO5
Molecular Weight: 383.44
- UPC:
- 51111606
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D658915-5mg
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





